Navigation Links
34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research
Date:12/6/2009

SEATTLE, Dec. 6 /PRNewswire/ -- A challenge donation from the Bezos family at Saturday's Hutch Holiday Gala boosted the evening's fundraising total to more than $7 million for Fred Hutchinson Cancer Research Center.

"Help the Hutch," a portion of the live auction during which guests raise their bid cards for specific contribution levels, brought in $6.4 million to be directed toward the Hutchinson Center's work to harness the human immune system to battle cancer.

The black-tie Gala took place Dec. 5 from 6 p.m. to midnight at the Seattle Sheraton Hotel. The Bezos family asked for unity to advance and broaden the Center's program in immunotherapy to fight solid-tumor cancers.

In November the family pledged $10 million to the Hutchinson Center to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages. The family chose to structure the gift as a challenge in the hope that it will unite others in the community to join the cause. The three-year challenge period kicked off during Saturday's Gala and will extend through Dec. 31, 2012.

Through the years the Center has led the development of immunotherapy, via bone marrow and stem cell transplantation, to help patients win the battle against leukemia and other blood cancers. These advancements greatly enhanced researchers' understanding of the body's ability to use antibodies, T cells and other immune-system components to fight disease. As a result of their successes, Center scientists believe they are uniquely poised to apply knowledge of the immune system to combat common cancers such as breast, prostate, colon, kidney, ovarian and skin cancer.

Recent discoveries in the Center's Clinical Research Division herald a new era in cancer treatment. An example is the work of Cassian Yee, M.D., who found that infusing patients with their own "helper" T cells could put advanced melanoma into remission. Yee and other Center researchers are now expanding clinical trials that use T cell therapy to treat advanced tumors.

"We are fortunate that our guests know the power of private support in the fight against cancer," Yee said. "Proceeds from tonight's Gala challenge and auction will help us advance all we've done in the lab - moving it into the clinic to help patients," he said.

Gala patrons also bid on exclusive auction packages including a trip to the Big Apple for the Tony Awards, $11,000.; a trip to French Polynesia to view a total solar eclipse, $14,000.; and an exclusive private tasting and dinner for 12 at Long Shadows and Corliss wineries in Walla Walla, $22,000.

The grand finale was the "Diamond Dash" - a raffle for a 30 second shopping spree at Alvin Goldfarb Jeweler's store in downtown Seattle. Sue Hansen held the winning ticket and, strapping on a new pair of Nike Flex running shoes donated for the occasion, ran for a pair of diamond-and-peridot drop earrings. "Diamond Dash" raffle ticket sales raised $30,600.

Presented by the Grace Heffernan Arnold Guild and the Hutch Holiday Gala Board of Directors, the Hutch Holiday Gala featured live and silent auctions, an elegant dinner and entertainment with 700 in attendance. Through the years the Gala has raised more than $62 million in support of key research initiatives and patient programs at the Hutchinson Center.

To learn more, visit the Hutch Holiday Gala Web page at www.fhcrc.org/gala and the Hutchinson Center Web site at www.fhcrc.org.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit www.fhcrc.org.


CONTACT:
Christi Ball Loso
206-667-5215
closo@fhcrc.org

SOURCE Fred Hutchinson Cancer Research Center


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
2. NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
3. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
4. Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
5. Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference
6. Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
7. Spherix Announces Results of Annual Shareholders Meeting
8. Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting
9. Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
10. Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
11. Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... DUBLIN , Feb. 10, 2016  Allergan plc ... today announced that Brent Saunders , Allergan,s CEO ... in a fireside chat session at the RBC Capital ... 12:30 p.m. ET at The New York Palace Hotel ... presentation will be webcast live and can be accessed ...
(Date:2/10/2016)... Springfield, MO (PRWEB) , ... February 10, 2016 ... ... company, will attend the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter ... of ISPE is expecting to fill more than 100 tables for its annual ...
(Date:2/10/2016)... ... 10, 2016 , ... PatientCrossroads announces that the ... online PatientCrossroads platform, has exceeded both its one-year and overall recruitment goals since ... which seeks to advance understanding of the hereditary risks for certain kinds of ...
(Date:2/10/2016)... ... ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused on the discovery and ... been selected to present at the Cavendish Global Health Impact Forum taking place February ... of the Forum is to help family offices and foundations develop and implement their ...
Breaking Biology Technology:
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... the addition of the "Global Facial ... offering. --> http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has ... Facial Recognition Market 2016-2020" report to ... Markets ( http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the ...
(Date:2/3/2016)... , February 4, 2016 --> ... to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of ... amounted to SEK 517.6 M (loss: 30.0). Earnings per share ... activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with ...
(Date:2/3/2016)... , Feb. 3, 2016 Vigilant Solutions ... Police Department in Missouri solved ... plate reader (LPR) data from Vigilant Solutions. ... case in which the victim was walking out of a convenience store and ... space next to his vehicle, striking his vehicle and ...
Breaking Biology News(10 mins):